Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07063732 · ClinicalTrials.gov registry record · NA
Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise
A NA study of Exercise and High Altitude Hypoxia, sponsored by McMaster University.
- Recruiting
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 2
- Study locations
NCT07063732: Recruiting NA study of Exercise and High Altitude Hypoxia, sponsored by McMaster University.
NCT07063732 is a NA study of Exercise and High Altitude Hypoxia that is actively recruiting participants, run by McMaster University. The registered enrollment target is 14 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07063732, a NA study of Exercise and High Altitude Hypoxia, is actively recruiting participants, sponsored by McMaster University.
- RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this trial is to investigate the effect of acute ketone monoester ingestion (0.6 g KME/kg body weight) on the occurrence of the ventilatory threshold and the subsequent response of blood velocity in cerebral arteries during a maximal exercise test at low altitude and high altitude.
Primary Outcome
Transcranial Doppler ultrasound will be used to measure blood velocity in the middle cerebral artery and posterior cerebral artery. Location of measurements will remain consistent within participants.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Ketone Monoester (KME)
Study Locations (2)
California
- Barcroft Research Station - Bishop
Ontario
- University of Guelph - Guelph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What NCT07063732 shows while recruiting
NCT07063732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07063732 reports a single indexed study location in California, Ontario.
Frequently Asked Questions
What is clinical trial NCT07063732 about?
NCT07063732 is a clinical study titled "Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise". The purpose of this trial is to investigate the effect of acute ketone monoester ingestion (0.6 g KME/kg body weight) on the occurrence of the ventilatory threshold and the subsequent response of blood velocity in cerebral arteries during a maximal exercise test at low altitude and high altitude.
What is the current status of trial NCT07063732?
This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-05-28. Estimated completion is 2025-08-31.
What conditions does trial NCT07063732 study?
This clinical trial studies the following conditions: Exercise, High Altitude Hypoxia.
What interventions are being tested in trial NCT07063732?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Ketone Monoester (KME) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07063732?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07063732 being conducted?
This trial has 2 study locations across California, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07063732's enrollment target sits among peer trials
14 57th of 57 higher than 1 of 57 other Exercise trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy